NEJM Interviews NEJM Interview: Kushal Kadakia on the 21st Century Cures Act, Cures 2.0, and lessons from Covid-19 for medical product development.
May 4, 2022
Chapters
Transcript
Episode notes
1 2 3 4 5
Introduction
00:00 • 2min
What Are the Main Provisions of the 20 16 Legislation?
02:06 • 3min
What We Learned From the Pandemic
05:06 • 2min
The Role of Rural Evidence in Product Approval
06:43 • 3min
How Can We Better Harmonize Approval and Coverage Decisions Between the FDA and the Centers for Medical Services?
09:25 • 2min